Merger between CareFusion and Becton, Dickinson and Company ‘approved’

Today (January 22nd), CareFusion and Becton, Dickinson and Company announced that their proposed merger had been approved by stockholders.

The meeting, held yesterday, was for stakeholders to consider and vote on the potential deal put before them.

They approved the definitive merger agreement and the transaction, with around 76 per cent of shares outstanding cast in favour of the proposal.  

As previously announced on October 5th 2014, medical device maker CareFusion entered into a contract that would see Becton, Dickinson and Company purchase it in a stock and cash deal worth $12.2 billion (8.02 billion pounds), the only caveat was stockholder agreement.

Although it has been accepted, the proposed acquisition is still subject to certain other conditions, such as approval by the European Commission under the European Union Merger Regulation.

San Diego-based CareFusion is a global medical technology company that provides devices to health industries across the world. It specialises in two areas: reducing medication errors and the prevention of healthcare-associated infections.